Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deep Track Capital
Greenwich, Connecticut, United Statesdeeptrackcapital.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Deep Track Capital is an investment management firm focused exclusively on the life sciences sector. It partners with public and pre-public biotechnology companies, providing capital and strategic support. The firm manages approximately $4–5 billion in assets and has invested in over 100 biotech/life science companies since its founding in 2021.
It does not conduct clinical trials or have its own drug pipeline but holds significant positions in leading biotech firms such as Dynavax Technologies Corporation, Insmed Inc., Protagonist Therapeutics, Akero Therapeutics, Tarsus Pharmaceuticals, BridgeBio Pharma, Ionis Pharmaceuticals, Guardant Health Inc., Dynavax Technologies. Its investments span a wide range of therapeutic areas through its portfolio.
The company’s leadership includes founder David Kroin and managing directors Rael Mazansky and Gerard Smith.
As an investor rather than an operator or developer of therapies itself, it has no direct clinical results or programs.
- Industry
- Investors
02
Partnerships
Invests alongside other major healthcare investors/syndicates but no disclosed formal partnerships typical of operating biotechs/pharmasSignificant shareholder/investor relationships with many public/private biotech firms including Dynavax Technologies CorporationInsmed Inc.Protagonist Therapeutics etc.
Beyond the preview
Go deeper on Deep Track Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Deep Track Capital.